Legal analysis: On October 29th, 65438, the State Administration of Pharmaceutical Products issued a notice, requesting to modify the instructions of anti-inflammatory preparations of Pudilan (including tablets, capsules and oral liquid), and to modify the "adverse reactions", "contraindications" and "precautions". Subsequently, on June 6th, 165438+, the over-the-counter instructions of pudilan Xiaoyan tablets (capsules) were forcibly revised.

The fact that Pu was ordered to revise the instructions does not mean that he was banned.

Legal basis: Article 28 of the Social Insurance Law of People's Republic of China (PRC) conforms to the basic medical insurance drug list, diagnosis and treatment items, medical service facilities standards and emergency and rescue medical expenses, and shall be paid from the basic medical insurance fund in accordance with state regulations.